Arun Puranik
Radiation Oncology · Latham, NYNPI 1609950542
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,298 of the $1,725 with a category attached, or 75.2%. Siemens Medical Solutions USA, Inc. accounts for 84.8% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $1,463, 6.2 times the $234 reported in 2019.
Across 5 payments — averaging $345.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$1K
- Brainlab, Inc.$234
- Teleflex LLC$28
What the payments were for
- Travel & lodging$1,29875%
- Food & beverage$42725%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 3 | $1,463 |
| Brainlab, Inc. | 1 | $234 |
| Teleflex LLC | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edge$1,463
How this compares
$1,725 in reported general payments places this provider in the 75th percentile of 397 radiation oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 26 | $68,935 |
| GemtesaVibegron | 28 | $13,987 |
| Tamsulosin Hcl | 229 | $2,345 |
| Norethindrone Acetate | 46 | $1,731 |
| Bicalutamide | 11 | $258 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 22 | $257 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Latham
- Chung ChungSyracuse$3.1M
- Michael ZelefskyNew York$946K
- Jeffrey BogartSyracuse$772K
- Steven FinkelsteinSyracuse$578K
- Shawn ZimbergPlainview$411K
- Edward ObedianOyster Bay$391K
- Nancy LeeNew York$233K
- Dheerendra PrasadBuffalo$178K
- Robert SamsteinNew York$125K
- Jalal AhmedNew York$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.